Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Dandan Huo"'
Autor:
Zhenxing Yang, Tao Huang, Chong Sheng, Kaijuan Wang, Yilin Li, Yajing Feng, Dandan Huo, Fujiao Duan
Publikováno v:
Cancer Reports, Vol 7, Iss 1, Pp n/a-n/a (2024)
Abstract Background Long non encoding RNA (lncRNA) plays a crucial role in breast cancer. However, the prognostic role of AFAP1‐AS1 in breast cancer remains unclear. Aims To investigate the relationship between the expression of long non‐coding R
Externí odkaz:
https://doaj.org/article/5b2649376132439bb2bc129954ac8435
Autor:
Jia Xu, Hong Zhang, Hong Chen, Xiaoxue Zhu, Haiyan Jia, Zhongnan Xu, Dandan Huo, Cuiyun Li, Yanhua Ding
Publikováno v:
Annals of Medicine, Vol 55, Iss 2 (2023)
AbstractBackground: TQA3526 is a novel farnesoid X receptor agonist developed to treat non-alcoholic steatohepatitis (NASH) or primary biliary cholangitis (PBC). This study aimed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharma
Externí odkaz:
https://doaj.org/article/21c9bbece98d4361bc32077cb24b1fdd
Autor:
Jingrui Liu, Xiaoxue Zhu, Hong Zhang, Haijing Wei, Deming Yang, Zhongnan Xu, Dandan Huo, Xiaojiao Li, Yanhua Ding
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: As a novel dipeptidyl peptidase-4 (DPP-4) inhibitor, TQ-F3083 represents a promising new drug for type 2 diabetes mellitus (T2DM). This phase I, first-in-human study evaluated the tolerability, pharmacokinetics, and pharmacodynamics of TQ
Externí odkaz:
https://doaj.org/article/88320d38bf4a4660b4ac8c59888c2af2
Autor:
Li Tian, Bingyu Yan, Dandan Huo, Wenhui Sun, Sufang Cui, Xiaojing Li, Xiangmei Zhang, Huijun Dong
Publikováno v:
Biotechnology Letters. 45:401-410
Autor:
Liviawati S Wu, Yue Hu, Edward J Gane, Leen Slaets, An De Creus, Yanhua Ding, Junqi Niu, Christian Schwabe, Nele Goeyvaerts, Zhongnan Xu, Dandan Huo, Marianne Tuefferd, Inge Verbrugge, Pieter Van Remoortere, Ullrich Schwertschlag, Joris Vandenbossche
Publikováno v:
Antiviral Therapy. 28:135965352311516
Background JNJ-4964 is a TLR7 agonist, which, via a type I interferon (IFN)–dependent mechanism, may enhance host immunity suppressed by persistent exposure to hepatitis B antigens in chronic hepatitis B. Methods PK and PD data were pooled from 2 s
Autor:
Yanhua Ding, Deming Yang, Zhongnan Xu, Haijing Wei, Xiaoxue Zhu, Hong Zhang, Dandan Huo, Jingrui Liu, Xiaojiao Li
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
Background: As a novel dipeptidyl peptidase-4 (DPP-4) inhibitor, TQ-F3083 represents a promising new drug for type 2 diabetes mellitus (T2DM). This phase I, first-in-human study evaluated the tolerability, pharmacokinetics, and pharmacodynamics of TQ
Autor:
Yue Hu, Min Wu, Wenbo zheng, Li Liu, Yanhua Ding, Hong Zhang, Dandan Huo, Meng Wang, Deming Yang, Zhongnan Xu, Xiaojiao Li, Cuiyun Li
Publikováno v:
Clinical Pharmacology in Drug Development.
The present study assessed the pharmacokinetics and bioequivalence of a single 10-mg dose of a generic and the branded formulation (Ocaliva) of obeticholic acid (OCA) in healthy Chinese subjects under fasting and fed conditions. The possible effects
Autor:
Jia Xu, Hong Zhang, Hong Chen, Xiaoxue Zhu, Zhong-Nan Xu, Dandan Huo, Haiyan Jia, Yanhua Ding, Junqi Niu
Publikováno v:
Journal of Hepatology. 73:S466
Autor:
Xiaojiao Li, Hong Zhang, Dandan Huo, Yue Hu, Min Wu, Hong Chen, Junqi Niu, Zhongnan Xu, Yanhua Ding
Publikováno v:
Journal of Hepatology. 70:e466-e467
Publikováno v:
2009 Fourth International Conference on Communications and Networking in China.
Identifying elephant flows is very important in developing effective and efficient traffic engineering schemes. In addition, obtaining the statistics of these flows is also very useful for network operation and management. In this paper, we propose a